C21 Investments Inc. (CWLXF): Operating Income

Annual figures by period end, from SEC filings.

$2.28M
Year ended 2026-03-31
$9.75M2021-01-31: $9.24M2022-01-31: $9.75M2023-01-31: $3.96M2024-01-31: $1.47M2025-03-31: $1.28M2026-03-31: $2.28M$2.28M
2021-01-31 Operating Income (USD) 2026-03-31
Period endedOperating IncomeChange YoYSource filing
2026-03-31$2.28M+77.8%2026-06-12, From 2025-04-01
2025-03-31$1.28Mn/a2026-06-12, From 2024-04-01
No annual figure between 2024-01-31 and 2025-03-31.
2024-01-31$1.47M-62.8%2025-06-23, From 2023-02-01
2023-01-31$3.96M-59.5%2024-08-08, From 2022-02-01
2022-01-31$9.75M+5.6%2023-07-28, From 2021-02-01
2021-01-31$9.24Mn/a2023-07-28, From 2020-02-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
C21 Investments Inc. (CWLXF)2026-03-31$2.28M+77.8%
Leef Brands Inc. (LEEEF)2025-12-31-$7.59Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$8.46Mn/m
Cyanotech Corp (CYAN)2025-03-31-$2.51Mn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$2.17Mn/m
Bon Natural Life Ltd (BON)2025-09-30-$1.62Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$10.06M-23.3%
Mannatech Inc (MTEX)2025-12-31-$426.0Kn/m
Niagen Bioscience, Inc. (NAGE)2025-12-31$16.28M+110.7%

Compare CWLXF, LEEEF, SNYRQ, CYAN side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗